1-bromo-3-(4-octylphenoxy)propan-2-ol | 741606-01-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-bromo-3-(4-octylphenoxy)propan-2-ol
• CAS: 741606-01-9
• 化学式: C₁₇H₂₇BrO₂
• 分子量: 343.304
• InChiKey: IYVHUOCWPZQZNP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.1
• 重原子数：
  20
• 可旋转键数：
  11
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.65
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-bromo-3-(4-octylphenoxy)propan-2-ol 在 吡啶 、 potassium tert-butylate 、 sodium methylate 、 乙酸酐 、 二甲基亚砜 、 三氟乙酸 作用下， 以 甲醇 、 二氯甲烷 、 二甲基亚砜 为溶剂， 反应 14.0h， 生成 1-[3-(4-octylphenoxy)-2-oxo-propyl]indole-3-carboxylic acid
  参考文献：
  名称：

  Design and Synthesis of 1-Indol-1-yl-propan-2-ones as Inhibitors of Human Cytosolic Phospholipase A₂α

  摘要：

  The synthesis and structure-activity relationship study of a series of 1-indol-1-yl-3-phenoxypropan-2-one inhibitors of cytosolic phospholipase A(2)alpha (cPLA(2)alpha) are described. The compounds were evaluated in a vesicle assay with isolated cPLA(2)alpha and in cellular assays with intact human platelets. Systematic variation led to 3-methylhydrogen 1-[3-(4-decyloxyphenoxy)-2-oxopropyl]indole-3,5-dicarboxylate (57), which revealed the highest activity against the isolated enzyme. With an IC50 value of 4.3 nM in this assay, it is one of the most potent in vitro cPLA(2)alpha inhibitors known today.

  DOI：

  10.1021/jm051243a
• 作为产物：
  描述：

  4-辛基酚 在 氢氧化钾 、 四丁基溴化铵 、 silica gel 、 lithium bromide 作用下， 以 二氯甲烷 为溶剂， 反应 8.0h， 生成 1-bromo-3-(4-octylphenoxy)propan-2-ol
  参考文献：
  名称：

  Design and Synthesis of 1-Indol-1-yl-propan-2-ones as Inhibitors of Human Cytosolic Phospholipase A₂α

  摘要：

  The synthesis and structure-activity relationship study of a series of 1-indol-1-yl-3-phenoxypropan-2-one inhibitors of cytosolic phospholipase A(2)alpha (cPLA(2)alpha) are described. The compounds were evaluated in a vesicle assay with isolated cPLA(2)alpha and in cellular assays with intact human platelets. Systematic variation led to 3-methylhydrogen 1-[3-(4-decyloxyphenoxy)-2-oxopropyl]indole-3,5-dicarboxylate (57), which revealed the highest activity against the isolated enzyme. With an IC50 value of 4.3 nM in this assay, it is one of the most potent in vitro cPLA(2)alpha inhibitors known today.

  DOI：

  10.1021/jm051243a

文献信息

• [DE] NEUE HETEROARYLSUBSTITUIERTE ACETONDERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A2<br/>[EN] NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A2<br/>[FR] NOUVEAUX DERIVES D'ACETONE A SUBSTITUTION HETEROARYLE SERVANT D'INHIBITEURS DE PHOSPHOLIPASE A2
  申请人：MERCKLE GMBH

  公开号：WO2004069797A1

  公开（公告）日：2004-08-19

  Die Erfindung betrifft neuartige Heteroaryl-substituierte Acetonderivate welche das Enzym Phospholipase A2 hemmen, pharmazeutische Mittel, die diese Verbindungen enthalten und ein Verfahren zur Herstellung dieser Verbindungen.

  这项发明涉及新型杂环芳基取代的乙酰衍生物，可以抑制磷脂酶A2酶，包含这些化合物的制药物以及制备这些化合物的方法。
• Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2
  申请人：Lehr Matthias

  公开号：US20060142366A1

  公开（公告）日：2006-06-29

  The invention relates to novel heteroaryl substituted acetone derivatives which inhibit the enzyme phospholipase A 2 , pharmaceutical preparations containing these compounds and a method of producing these compounds.

  本发明涉及新型杂环取代丙酮衍生物，其抑制磷脂酶A2酶，包含这些化合物的药物制剂以及制备这些化合物的方法。
• Heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2
  申请人：Merckle GmbH

  公开号：US07608633B2

  公开（公告）日：2009-10-27

  The invention relates to novel heteroaryl substituted acetone derivatives which inhibit the enzyme phospholipase A2, pharmaceutical preparations containing these compounds and a method of producing these compounds.

  该发明涉及新型杂环取代丙酮衍生物，其抑制磷脂酶A2酶，包含这些化合物的制药制剂和制备这些化合物的方法。
• 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A2α and fatty acid amide hydrolase
  作者：Laura Forster、Joachim Ludwig、Martina Kaptur、Stefanie Bovens、Alwine Schulze Elfringhoff、Angela Holtfrerich、Matthias Lehr

  DOI：10.1016/j.bmc.2009.11.028

  日期：2010.1

  Cytosolic phospholipase A(2)alpha (cPLA(2)alpha) and fatty acid amide hydrolase (FAAH) are enzymes, which have emerged as attractive targets for the development of analgetic and anti-inflammatory drugs. We recently reported that 1-[3-(4-octylphenoxy)-2-oxopropyl]indole-5-carboxylic acid (10) and related compounds are inhibitors of cPLA(2)alpha. Since cPLA(2)alpha and FAAH possess several common structural features, we now screened this substance series together with some new derivatives for FAAH inhibition. Some of the assayed compounds proved to be selective cPLA(2)alpha inhibitors, while others showed high FAAH and moderate cPLA(2)alpha inhibitory potency. Furthermore, several derivatives were favorably active against both enzymes and, therefore, could represent agents, which have improved analgetic and anti-inflammatory qualities in comparison with selective cPLA(2)alpha and FAAH inhibitors. (C) 2009 Elsevier Ltd. All rights reserved.
• NEUE HETEROARYLSUBSTITUIERTE ACETONDERIVATE ALS HEMMSTOFFE DER PHOSPHOLIPASE A sb 2 /sb
  申请人：MERCKLE GMBH

  公开号：EP1590324A1

  公开（公告）日：2005-11-02